BatemanR. J.XiongC.BenzingerT. L.FaganA. M.GoateA.FoxN. C.Dominantly Inherited Alzheimer Network (2012) Clinical and biomarker changes in dominantly inherited AD. The New England Journal of Medicine367(9): 795–804.
2.
MorrisJ. C. (2012) Revised criteria for mild cognitive impairment may compromise the diagnosis of AD dementia. Archives of Neurology69(6): 700–708.
3.
MorrisJ. C.RoeC. M.XiongC.FaganA. M.GoateA. M.HoltzmanD. M.MintunM. A. (2010) APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Annals of Neurology67(1): 122–131.
4.
RoeC. M.FaganA. M.GrantE. A.HassenstabJ.MoulderK. L.DreyfusD. M.MorrisJ. C. (2013) Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology80: 1784–1791.
5.
VosS. J.XiongC.VisserP. J.JasielecM. S.HassenstabJ.GrantE. A.FaganA. M. (2013) Preclinical AD and its outcome: A longitudinal cohort study. The Lancet Neurology12(10): 957–965.
